Clinical Trials Browser

Phase NA × OTHER_GOV × apatinib × Clear all

NCT03228043 2024-11-14

Apatinib for Resectable Colorectal Cancer

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT05380986 2022-05-19

Camrelizumab Combined With Apatinib Mesylate

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT04174339 2019-11-22

PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer

Phase NA Unknown

Gastrointestinal

Advanced Gastric Adenocarcinoma